Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
Steven A. Kemp, Bo Meng, Isabella ATM Ferriera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3370
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1215
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz, Swapnil Mishra, Meera Chand, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 266-269
Open Access | Times Cited: 1189
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1178
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp, Dami A. Collier, Rawlings Datir, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 277-282
Open Access | Times Cited: 984
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 917-924
Closed Access | Times Cited: 732
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier, Anna De Marco, Isabella A. T. M. Ferreira, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 136-141
Open Access | Times Cited: 692
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
Erik Volz, Swapnil Mishra, Meera Chand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 649
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, et al.
The Lancet (2021) Vol. 397, Iss. 10282, pp. 1351-1362
Open Access | Times Cited: 624
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 515
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
Kaichun Wu, Anne P. Werner, Juan I. Moliva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 473
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 402
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2316-2331.e15
Open Access | Times Cited: 382
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 529-539.e3
Open Access | Times Cited: 377
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
Ai‐ris Y. Collier, Katherine McMahan, Jingyou Yu, et al.
JAMA (2021) Vol. 325, Iss. 23, pp. 2370-2370
Open Access | Times Cited: 370
SARS-CoV-2 within-host diversity and transmission
Katrina Lythgoe, Matthew Hall, Luca Ferretti, et al.
Science (2021) Vol. 372, Iss. 6539
Open Access | Times Cited: 369
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
Face masks effectively limit the probability of SARS-CoV-2 transmission
Yafang Cheng, Nan Ma, Christian Witt, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1439-1443
Open Access | Times Cited: 309
Emergence of a new SARS-CoV-2 variant in the UK
Julian W. Tang, Paul Anantharajah Tambyah, David S.C. Hui
Journal of Infection (2020) Vol. 82, Iss. 4, pp. e27-e28
Open Access | Times Cited: 287
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Carmen Gómez, Beatriz Perdiguero, Mariano Estéban
Vaccines (2021) Vol. 9, Iss. 3, pp. 243-243
Open Access | Times Cited: 267
The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear, Luke Muir, Sarah Griffith, et al.
Cell Reports (2021) Vol. 34, Iss. 12, pp. 108890-108890
Open Access | Times Cited: 235
Will SARS-CoV-2 variants of concern affect the promise of vaccines?
Ravindra K. Gupta
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 340-341
Open Access | Times Cited: 201
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 199
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina, Yara Khalaila, Olga Voloshin, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 522-528.e2
Open Access | Times Cited: 192
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Page 1 - Next Page

Scroll to top